Black Rock Inc. Esperion Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,838,820 shares of ESPR stock, worth $5.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,838,820

Previous 2,112,899 34.36%

Holding current value

$5.93 Million

Previous $6.32 Million 20.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.02 - $3.02 $1.47 Million - $2.19 Million	725,921 Added 34.36%	2,838,820 $7.61 Million
Q4 2023 Feb 13, 2024	BUY	$0.73 - $3.08 $105,864 - $446,661	145,020 Added 7.37%	2,112,899 $6.32 Million
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $634,009 - $1.18 Million	660,427 Added 50.51%	1,967,879 $1.93 Million
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.76 $4.22 Million - $6.19 Million	-3,515,736 Reduced 72.89%	1,307,452 $1.82 Million
Q1 2023 May 12, 2023	SELL	$1.46 - $7.3 $1 Million - $5.01 Million	-685,999 Reduced 12.45%	4,823,188 $7.67 Million

Q4 2022 Feb 13, 2023	BUY	$5.09 - $8.5 $4.84 Million - $8.08 Million	950,543 Added 20.85%	5,509,187 $34.3 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $1.44 Million - $2.15 Million	264,412 Added 6.16%	4,558,644 $30.5 Million
Q2 2022 Aug 12, 2022	BUY	$4.77 - $6.67 $2.53 Million - $3.54 Million	530,492 Added 14.09%	4,294,232 $27.3 Million
Q1 2022 May 12, 2022	BUY	$3.34 - $5.56 $5.09 Million - $8.47 Million	1,522,523 Added 67.93%	3,763,740 $17.5 Million
Q4 2021 Feb 10, 2022	BUY	$4.81 - $11.92 $1.13 Million - $2.8 Million	235,083 Added 11.72%	2,241,217 $11.2 Million
Q3 2021 Nov 09, 2021	SELL	$11.34 - $21.37 $898,275 - $1.69 Million	-79,213 Reduced 3.8%	2,006,134 $24.2 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $28.71 $40.5 Million - $59.9 Million	2,085,347 New	2,085,347 $44.1 Million

Others Institutions Holding ESPR

# of Institutions

174

Shares Held

125M

Call Options Held

2.08M

Put Options Held

1.01M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $139M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account